2.9(top 20%)
impact factor
779(top 20%)
papers
11.4K(top 20%)
citations
50(top 10%)
h-index
3.0(top 20%)
extended IF
794
all documents
12.3K
doc citations
78(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studiesThrombosis Journal2013471
2Development of an in vitro model to study clot lysis activity of thrombolytic drugsThrombosis Journal2006223
3Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseasesThrombosis Journal2019200
4Hereditary thrombophiliaThrombosis Journal2006189
5A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysisThrombosis Journal2015171
6Contact pathway of coagulation and inflammationThrombosis Journal2015156
7Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implicationsThrombosis Journal2007153
8Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoringThrombosis Journal2013141
9Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapiesThrombosis Journal2016141
10Laboratory assessment of rivaroxaban: a reviewThrombosis Journal2013134
11Sepsis and septic shock: endothelial molecular pathogenesis associated with vascular microthrombotic diseaseThrombosis Journal2019133
12Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and HemostasisThrombosis Journal2016130
13Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assayThrombosis Journal2005112
14Thrombosis in vasculitis: from pathogenesis to treatmentThrombosis Journal2015112
15Evaluation of the TEG platelet mapping assay in blood donorsThrombosis Journal2007110
16Heparin-induced thrombocytopenia: an updateThrombosis Journal2005108
17Thrombosis in inflammatory bowel diseases: what’s the link?Thrombosis Journal201599
18The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patientsThrombosis Journal201194
19Perioperative management of patients on direct oral anticoagulantsThrombosis Journal201792
20Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterolThrombosis Journal201290
21Hypothermia: effects on platelet function and hemostasisThrombosis Journal201490
22Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE programThrombosis Journal201590
23The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?Thrombosis Journal200489
24Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratoriesThrombosis Journal201688
25Blood coagulation and the risk of atherothrombosis: a complex relationshipThrombosis Journal200486
26Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regressionThrombosis Journal201486
27Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysisThrombosis Journal201883
28Venous thromboembolism in the elderly: efficacy and safety of non-VKA oral anticoagulantsThrombosis Journal201478
29Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levelsThrombosis Journal200577
30Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-VThrombosis Journal201577
31Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysisThrombosis Journal202076
32Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathyThrombosis Journal201875
33Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis riskThrombosis Journal201570
34DOACs – advances and limitations in real worldThrombosis Journal201669
35Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activityThrombosis Journal201667
36The diagnosis and treatment of venous thromboembolism in Asian patientsThrombosis Journal201865
37Human blood platelets and viruses: defense mechanism and role in the removal of viral pathogensThrombosis Journal201864
38Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective studyThrombosis Journal201863
39Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulationThrombosis Journal200662
40Circulating histone H3 levels in septic patients are associated with coagulopathy, multiple organ failure, and death: a single-center observational studyThrombosis Journal201962
41Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhageThrombosis Journal200459
42Assays of different aspects of haemostasis – what do they measure?Thrombosis Journal201559
43Resolution of left atrial appendage thrombus with apixabanThrombosis Journal201358
44Causes of venous thrombosisThrombosis Journal201657
45New oral anticoagulants: discussion on monitoring and adherence should start now!Thrombosis Journal201356
46TEG® and RapidTEG® are unreliable for detecting warfarin-coagulopathy: a prospective cohort studyThrombosis Journal201456
47Systemic lupus erythematosus and thrombosisThrombosis Journal201556
48Predictive risk factors of venous thromboembolism (VTE) associated with peripherally inserted central catheters (PICC) in ambulant solid cancer patients: retrospective single Centre cohort studyThrombosis Journal201956
49Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairmentThrombosis Journal201455
50NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The NetherlandsThrombosis Journal201855